Optometrists in Walker, MI Accepting Medicare

10 Optometrists found. Showing 1 - 10

Rx Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4482 Lake Michigan Dr Nw, Walker, MI 49534 Phone: 616-791-6944    Fax: 616-791-7268

Eric James, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3303 Alpine Ave Nw Ste A, Walker, MI 49544 Phone: 616-649-4703    Fax: 616-784-2634

Rx Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3576 Alpine Ave Nw, Walker, MI 49544 Phone: 616-784-4999    Fax: 616-784-7999

Rx Optical Laboratories, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4482 Lake Michigan Dr Nw, Walker, MI 49534 Phone: 616-791-6944

Dr. Andrew Paul Bringard, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4482 Lake Michigan Dr Nw, Walker, MI 49534 Phone: 616-791-6944    Fax: 616-791-7298

Rx Optical Laboratories, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3576 Alpine Ave Nw, Walker, MI 49544 Phone: 616-784-4999

Svs Vision 16 Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3150 Alpine Ave Nw, Ste. F, Walker, MI 49544 Phone: 616-363-9831    Fax: 616-363-5510

Mr. David G Higley, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3576 Alpine Ave Nw, Walker, MI 49504 Phone: 616-784-4999    Fax: 269-342-4284

Andrew Thomas Beuker, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 3576 Alpine Ave Nw, Walker, MI 49544 Phone: 616-784-4999    Fax: 616-784-7999

National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3303 Alpine Ave Nw Ste A, Walker, MI 49544 Phone: 616-649-4703

News Archive

Scientists uncover new evidence of potential health risks from smoke-related chemicals

Scientists at Dana-Farber Cancer Institute and the Centers for Disease Control and Prevention have uncovered new evidence of the potential health risks of chemicals in tobacco and marijuana smoke.

WHO, WIPO, WTO release book on intellectual property and access to medical technologies

"For the first time, the three global intergovernmental bodies dealing with health, intellectual property and trade have pooled their expertise on a study of policies needed to advance medical and health technologies and to ensure they reach the people who need them," a WHO press release states.

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental New Drug Applications (sNDAs) filed on May 2, 2012 for XARELTO (rivaroxaban), an oral anticoagulant, seeking new indications to treat patients with deep vein thrombosis (DVT), pulmonary embolism (PE), and to prevent recurrent DVT and PE.

Sleep disruption leads to negativity bias, study shows

A sleepless night not only leaves us fatigued and distracted, it also makes us interpret things more negatively and makes us more likely to lose our temper.

Read more Medical News

› Verified 1 days ago